ACRO Launches YouTube Channel to Educate About Clinical Trials and CROs
In an effort to educate the public, media and policymakers about clinical trials and the growing role of clinical research organizations in the drug development process, the Association of Clinical Research Organizations (ACRO) has launched a YouTube channel @ACROHealthChannel.
“Increasingly, the ACRO member companies constitute the global drug development infrastructure,” said John Lewis, ACRO Vice President of Public Affairs. “With a footprint now in 115 countries and responsibility for annually conducting more than 11,000 clinical trials involving two million participants, we have an obligation to engage and educate our various constituencies about issues effecting clinical research. These topics range from ensuring human subject protections to cultivating favorable regulatory and economic environments that promote more efficient drug development.”
The first two videos on ACROHealthChannel feature 2012 ACRO Chairman Jeff McMullen, President and CEO of PharmaNet/i3, discussing the association’s agenda for the year, and Neil McCollough, Vice President of Global Quality and Compliance at Pharmaceutical Product Development, LLC (PPD), discussing issues surrounding bioethics and the globalization of research.
“ACRO strives to be a resource for anyone in the world who is interested in clinical research and drug development,” said Lewis. “We find the ACROHealthChannel, our Twitter feed @acrohealth, and other social media to be effective communications tools to reach a broad audience.”
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
